Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.47 USD | -2.76% | -4.26% | +6.01% |
05-09 | Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q1 Revenue $98,000 | MT |
05-09 | VYNE Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.01% | 35.88M | |
+42.60% | 748B | |
+32.34% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.47% | 245B | |
+9.26% | 211B | |
-5.07% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- VYNE Stock
- News VYNE Therapeutics Inc.
- Transcript : Foamix Pharmaceuticals Ltd., Menlo Therapeutics Inc. - M&A Call